Oncotarget

Efficacy of osimertinib against EGFRvIII+ glioblastoma.  11:2074-2082. 2020

Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort..  11:758. 2020

Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108).  11:758. 2020

Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.  10:4857-4867. 2019

Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin.  10:1360-1387. 2019

Dissecting the role of RNA modification regulatory proteins in melanoma.  10:3745-3759. 2019

Editorial plasmacytomas: Many faces of one disease, or many diseases with one face?.  10:257-258. 2019

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability (Oncotarget (2017) 8 (90123-90131) DOI: 10.18632/oncotarget.21485).  9:37077. 2018

Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.  9:36836-36848. 2018

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.  9:37662-37675. 2018

Revisiting entinostat as an immune-potentiating adjuvant.  9:37278-37279. 2018

Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes..  9:34122-34131. 2018

Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation.  9:33804. 2018

DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity..  9:31719-31743. 2018

Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model..  9:23532-23542. 2018

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.  9:22665-22679. 2018

Zinc finger protein 598 inhibits cell survival by promoting UV-induced apoptosis.  9:5906-5918. 2018

Implementation and utilization of the molecular tumor board to guide precision medicine..  57845-57854. 2017

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy. 2017

A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis.  99245-99260. 2017

Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.  91199-91208. 2017

Combination strategies enhance oncolytic virotherapy.  34020. 2017

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes 2017

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth 2017

Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition.  106661-106671. 2017

Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.  76574-76586. 2017

Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.  10809-10821. 2017

Genomic regulation of invasion by STAT3 in triple negative breast cancer.  8226-8238. 2017

Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.  70828-70840. 2017

Hoxa9 and Hoxa10 induce CML myeloid blast crisis development through activation of Myb expression.  98853-98864. 2017

Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling.  96171-96183. 2017

Implementation and utilization of the molecular tumor board to guide precision medicine.  57845-57854. 2017

Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.  29220. 2017

Molecular characterization of pro-metastatic functions of β4- integrin in colorectal cancer.  92333-92345. 2017

Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models.  9823-9834. 2017

Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.  47675-47690. 2017

PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability.  90123-90131. 2017

Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.  76644-76655. 2017

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling.  69264-69280. 2017

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.  20198-20212. 2017

RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.  38668-38681. 2017

RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.  16387-16400. 2017

Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21^WAF1/CIP1 and p27^KIP1 pathway.  17216-17228. 2017

Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.  20895-20908. 2017

Skeletal muscle measures and physical function in older adults with cancer: Sarcopenia or myopenia?.  33658-33665. 2017

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.  65090-65099. 2017

Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain.  105800-105808. 2017

miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20..  7:78667-78679. 2016

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.  7:53984-53996. 2016

KRAS^G12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway.  7:53153-53164. 2016

ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.  7:53599-53610. 2016

Isolation, identification, and characterization of novel nanovesicles.  7:41346-41362. 2016

Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effect.  7:33855-33865. 2016

Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.  7:28935-28946. 2016

CLEC4C p.K210del variant causes impaired cell surface transport in plasmacytoid dendritic cells of amyotrophic lateral sclerosis..  7:24942-24949. 2016

Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.  7:20621-20635. 2016

Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling.  7:16023-16037. 2016

Protein phosphatase, Mg²⁺/Mn²⁺-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.  7:15394-15409. 2016

Cilengitide in newly diagnosed glioblastoma: Biomarker expression and outcome.  7:15018-15032. 2016

Development of ⁸⁹Zr-ontuxizumab for in vivo TEM-1/endosialin PET applications.  7:13082-13092. 2016

A role for activated Cdc42 in glioblastoma multiforme invasion.  7:56958-56975. 2016

BAI1: From cancer to neurological disease.  7:17288-17289. 2016

Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients [Oncotarget, 7, 9, (2016), (10433-10447) DOI: 10.18632/oncotarget.7197].  7:60775. 2016

Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients.  7. 2016

Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.  7:86660-86674. 2016

Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.  7:1227-1241. 2016

Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.  7. 2016

HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.  7:11567. 2016

Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.  7:75407-75424. 2016

Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.  7:7899-7912. 2016

Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.  7:6088. 2016

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.  7:17991-18005. 2016

Melanin content in melanoma metastases affects the outcome of radiotherapy.  7:17844-17853. 2016

MicroRNAs for osteosarcoma in the mouse: A meta-analysis.  7:85650-85674. 2016

Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer.  7:86803-86815. 2016

Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).  7:8756-8770. 2016

RORβ and RORη expression inversely correlates with human melanoma progression.  7:63261-63282. 2016

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.  7:79828-79841. 2016

SIN3A and SIN3B differentially regulate breast cancer metastasis.  7:78713-78725. 2016

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.  7:1598-1607. 2016

The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.  7:84201. 2016

The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.  7:73739-73753. 2016

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.  7. 2016

VPO1 mediates oxidation of LDL and formation of foam cells.  7:35500-35511. 2016

A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells.  6:20121-20131. 2015

An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.  6:33237-33252. 2015

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.  6. 2015

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells.  6:27661-27673. 2015

Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.  6:1582-1593. 2015

DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.  6:26995-27007. 2015

Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.  6:12080-12093. 2015

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.  6:29860-29876. 2015

Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.  6:18819-18828. 2015

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.  6:28296-28311. 2015

Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia.  6:6535-6535. 2015

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.  6. 2015

Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis.  6. 2015

Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.  6:17805. 2015

Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer.  6:43065-43080. 2015

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.  6:27763-27777. 2015

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.  6:17895. 2015

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis.  6:39088-39097. 2015

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.  6:23445-23461. 2015

Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.  6. 2015

Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia.  6:44161-44178. 2015

The host cell side of latent HIV-1 infection.  6:19920-19921. 2015

Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?.  5:5-6. 2014

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.  5:5218. 2014

Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.  5:1382-1389. 2014

Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.  5:3350-3361. 2014

Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo.  5:7917-7935. 2014

GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.  5:12151-12165. 2014

GSK-3 as potential target for therapeutic irvention in cancer.  5:2881-2911. 2014

MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.  5:3512-3525. 2014

Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.  5:7065-7080. 2014

SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma.  5:9703-9709. 2014

The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.  5:6654. 2014

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breas cancer cells.  5:6484-6496. 2014

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer.  5:8750-8764. 2014

A conspiracy of glioma and endothelial cells to invade the normal brain.  2:1-4. 2011

Recent advances in anti-angiogenic therapy of cancer.  2:122-134. 2011

BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells..  8670.

CKS1 expression in melanocytic nevi and melanoma.  9:4173.

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy..  68038-68046.

MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.  9:28391-28407.

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263.  9:30465-30471.